Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,611.23
(
1.61%
)
US TECH 100
23,629.60
(
1.49%
)
Dow Jones
46,413.76
(
1.83%
)
Brent Oil
95.83
(
-11.38%
)
Bitcoin
70,913.94
(
4.53%
)
News Focus
News Focus
Post# of 257272
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 228597

Tuesday, 02/18/2020 3:34:48 PM

Tuesday, February 18, 2020 3:34:48 PM

Post# of 257272
(RVNC)—Allergan’s CoolSculpting franchise has become a commercial bust. 4Q19 worldwide sales of CoolSculpting consumables were $53.0M, -32% YoY, while 4Q19 worldwide sales of CoolSculpting systems/upgrades were $25.7M. -47% YoY (https://allergan.gcs-web.com/node/22536/pdf ).

Mark Foley* struck a helluva deal when he sold ZLTQ to AGN for $2.5B three years ago (#msg-128649430).

*Now CEO of RVNC.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today